Trials / Active Not Recruiting
Active Not RecruitingNCT03347318
Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease
Non-interventional Study for the Determination of Molecular Resistance Profiling to Targeted Therapies in Patients With Neoplastic Disease
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (estimated)
- Sponsor
- Fondazione del Piemonte per l'Oncologia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to define the molecular profile of selected solid tumors. From each participants will be collected biological materials for molecular analysis, including saliva, blood and vital tumor tissue derived form surgical or biopsy procedures. Whereas possible, vital tumor specimens will be inoculated and propagated in immunocompromised NOD/SCID mice to study the genetic correlations between genetic status and response to target drugs.
Conditions
Timeline
- Start date
- 2011-03-30
- Primary completion
- 2026-03-15
- Completion
- 2026-03-31
- First posted
- 2017-11-20
- Last updated
- 2026-03-19
Locations
15 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03347318. Inclusion in this directory is not an endorsement.